| In millions, except per share items | Jun-30-14 | Mar-31-14 | Dec-31-13 | Sep-30-13 | Jun-30-13 | Mar-31-13 | Dec-31-12 | Sep-30-12 |
| | 10-Q | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues: |
| Sales Related Adjustments | | | | | | 9.6 | | |
| Patient Care Market Sales | | | 41.0 | | | | 40.0 | |
| Clinical Care Market Sales | | | 72.4 | | | | 72.8 | |
| Other | | | | | | 98.3 | | |
| Total revenues | 71.9 | 72.5 | 110.0 | 108.3 | 71.5 | 107.9 | 109.4 | 112.1 |
| Revenue growth [+] | 0.6% | -32.8% | 0.5% | -3.4% | -36.3% | -0.3% | -3.2% | 2.2% |
| Patient Care Market Sales | | | 2.5% | | | | | |
| Clinical Care Market Sales | | | -0.6% | | | | | |
| Cost of goods sold | 58.4 | 58.0 | 89.7 | 89.7 | 58.1 | 89.0 | 90.3 | 94.6 |
| Gross profit | 13.5 | 14.5 | 20.2 | 18.6 | 13.4 | 18.9 | 19.1 | 17.5 |
| Gross margin | 18.7% | 20.0% | 18.4% | 17.2% | 18.7% | 17.5% | 17.5% | 15.6% |
| Selling, general and administrative | 12.7 | 12.5 | 16.5 | 16.0 | 11.6 | 16.3 | 15.9 | 16.2 |
| Other operating expenses | | 1.5 | | | | | | |
| EBITDA [+] | 2.1 | | 5.8 | 3.2 | 4.6 | 4.9 | 5.4 | 3.5 |
| EBITDA growth | -54.1% | -89.7% | 8.2% | -9.9% | 40.9% | 299.1% | -14.9% | -9.7% |
| EBITDA margin | 2.9% | 0.7% | 5.3% | 2.9% | 6.4% | 4.5% | 4.9% | 3.2% |
| Depreciation | 0.8 | | 1.2 | -0.4 | 2.3 | 1.6 | 1.2 | 1.3 |
| EBITA | 1.3 | 0.5 | 4.6 | 3.5 | 2.3 | 3.3 | 4.1 | 2.3 |
| EBITA margin | 1.8% | 0.7% | 4.2% | 3.3% | 3.2% | 3.0% | 3.8% | 2.0% |
| Amortization of intangibles | 0.5 | | 0.9 | 0.9 | 0.5 | 0.7 | 0.9 | 0.9 |
| EBIT [+] | 0.8 | 0.5 | 3.8 | 2.7 | 1.8 | 2.6 | 3.2 | 1.3 |
| EBIT growth | -56.3% | -80.5% | 17.6% | 103.2% | 81.4% | -330.5% | -16.3% | -2.0% |
| EBIT margin | 1.1% | 0.7% | 3.4% | 2.4% | 2.5% | 2.4% | 2.9% | 1.2% |
| Non-recurring items [+] | | | | | | -0.8 | 78.6 | |
| Asset impairment | | | | | | -0.8 | 78.6 | |
| Interest expense | 0.8 | 0.7 | 0.7 | 0.9 | 1.7 | 1.2 | 1.1 | 1.2 |
| Interest expense | 0.8 | 0.7 | 0.7 | 0.9 | 1.7 | 1.2 | 1.1 | 1.2 |
| Other income (expense), net | | 1.5 | | | | | | |
| Pre-tax income | 0.0 | 1.3 | 3.0 | 1.7 | 0.2 | 2.2 | -76.6 | 0.1 |
| Income taxes | 0.0 | 0.9 | 1.1 | 0.6 | 0.1 | 1.5 | -21.1 | 0.0 |
| Tax rate | | 68.7% | 36.7% | 36.6% | 43.8% | 67.6% | 27.5% | 38.7% |
| Earnings from continuing ops | -12.0 | 0.4 | 1.9 | 1.1 | -0.1 | 0.7 | -55.5 | 0.1 |
| Earnings from discontinued ops | 12.0 | 0.4 | | | 0.2 | | | |
| Net income | 0.0 | 0.4 | 1.9 | 1.1 | 0.1 | 0.7 | -55.5 | 0.1 |
| Net margin | 0.0% | 0.5% | 1.7% | 1.0% | 0.1% | 0.7% | -50.7% | 0.1% |
| |
| Basic EPS [+] | ($0.73) | $0.02 | $0.12 | $0.07 | ($0.01) | $0.04 | ($3.39) | $0.00 |
| Growth | 11988.9% | -44.6% | -103.4% | 1589.2% | -27.7% | -129.2% | -3141.3% | -88.3% |
| Diluted EPS [+] | ($0.73) | $0.02 | $0.12 | $0.07 | ($0.01) | $0.04 | ($3.39) | $0.00 |
| Growth | 11984.5% | -44.9% | -103.4% | 1582.9% | -28.1% | -129.2% | -3141.3% | -88.3% |
| |
| Shares outstanding (basic) [+] | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.4 | 16.4 | 16.4 |
| Growth | 0.0% | 0.5% | 0.5% | 0.4% | 0.5% | 0.0% | 0.0% | 0.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |